Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary.

Slides:

Advertisements

Similar presentations

Date of download: 5/27/2016 From: Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial Ann Intern Med. 2013;158(9):

Advertisements

Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome Hitoshi Minamiguchi, MD, Shinsuke Nanto, MD, PhD,

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

Colloquium on Therapy of Right Heart Failure

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

The treatment of pulmonary sarcoidosis

Frontiers of anticoagulation therapy for atrial fibrillation

REVEAL Registry PAH Risk Score Calculator

Oxygen Therapy Titrated to Raise Mixed Venous Oxygen Content in COPD

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Volume 141, Issue 2, Pages (February 2012)

Ragesh Panikkath, MD, DNB, DM, Cynthia A

Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.

Pulmonary Arterial Hypertension: Early Recognition and Treatment Can Make a Lifetime Difference for Your Patient Carl A. Ross, RN, PhD, CRNP, BC, CNE

David R. Curran, MD, Terence K

Has the 6-Min Walk Distance Run Its Course?

Baffling Tachycardia The American Journal of Medicine

Comparison of the characteristics at first enrolment for United Network for Organ Sharing (UNOS) patients (n=8315) and virtual patients (n=2 048 784).

ECG: electrocardiogram; PFT: pulmonary function testing; Dlco: diffusion capacity of the lung for carbon monoxide; BGA: blood gas analysis; HRCT: high-resolution.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Diagnostic algorithm for pulmonary arterial hypertension (PAH).

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Risk stratification for lung nodules: Size isn't everything

Pulmonary hypertension in valve disease: A beast of the past?

Volume 126, Issue 1, Pages 14S-34S (July 2004)

Idiopathic Pulmonary Arterial Hypertension in Asians

Volume 146, Issue 6, Pages (December 2014)

Volume 146, Issue 5, Pages (November 2014)

Point: Adherence to Early Goal-Directed Therapy

Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation

Diagnostic algorithm. Diagnostic algorithm. PH: pulmonary hypertension; group: clinical group; TTE: transthoracic echocardiography; PFT: pulmonary function.

REVEAL pulmonary arterial hypertension (PAH) risk score.

Michael D. McGoon, MD, Abby Krichman, RRT, Harrison W

Cox proportional hazard estimates for multivariate model of survival, limited to terms included in the final stepwise model. Cox proportional hazard estimates.

A New Era of Renal Denervation Trials for Patients With Hypertension?

High-resolution computed tomography with three-dimensional reconstruction for assessment of chronic pulmonary thromboembolic disease Thoralf M. Sundt,

Case of the Month #158 Canadian Association of Radiologists Journal

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018 Stephan Rosenkranz, Irene.

An algorithm for the early diagnosis of pulmonary arterial hypertension in systemic sclerosis. An algorithm for the early diagnosis of pulmonary arterial.

Darren H. Freed, MD, PhD, FRCSC, Bruce M

Extent of interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD. A simple stratification that utilises pulmonary function.

An expert proposal for a treat-to-target checklist for pulmonary arterial hypertension (PAH). An expert proposal for a treat-to-target checklist for pulmonary.

Pulmonary Langerhans' Cell Histiocytosis

Selection of patients: 248 consecutive patients with newly diagnosed pre-capillary pulmonary hypertension were included in the study. Selection of patients:

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer Allison Ackerman, MD, Michael A. Goldstein,

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018

Bedside Calibration Of Pulmonary Artery Catheters

Micha T. Maeder, MD, PhD, Niklas F. Ehl, MD

Guidelines should bother us, not comfort us

Forest plots of the correlation between high-resolution computed tomography (HRCT) scores and pulmonary function test values. Forest plots of the correlation.

Simplified REVEAL (Registry to Evaluate Early And Long-term PAH Disease Management) risk score. Simplified REVEAL (Registry to Evaluate Early And Long-term.

Proposed screening algorithm for identification of pulmonary arterial hypertension (PAH) associated with connective tissue disease. Proposed screening.

Predicting Survival in Patients With Pulmonary Arterial Hypertension

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Cumulative count of the different primary pulmonary function test (PFT) outcomes in longitudinal studies of systemic sclerosis-associated interstitial.

Algorithm for the assessment of fitness to fly in chronic obstructive pulmonary disease patients. Algorithm for the assessment of fitness to fly in chronic.

Volume 100, Issue 6, Pages (December 1991)

Volume 133, Issue 4, Pages (April 2008)

Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: A safe and effective therapy? Christian Kuntzen, Veit Gülberg, Alexander.

Distribution of mutations in sporadic and familial pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary.

Answer to Case of the Month #158

Procedure for the diagnosis of interstitial lung diseases.

Distribution of diffusing capacity of the lung for carbon monoxide (DLCO) among 243 scleroderma patients who underwent right heart catheterisation (RHC)

Progression in the patient’s pulmonary function tests from 2010 to a) Forced vital capacity (FVC); b) total lung capacity (TLC); c) diffusing capacity.

Module 2: evaluation of the REVEAL risk score in the FPHN validation cohort. Module 2: evaluation of the REVEAL risk score in the FPHN validation cohort.

Presentation transcript:

Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary vasodilator therapy Hitoshi Koito, MD, PhD, FJCC Journal of Cardiology Cases Volume 5, Issue 3, Pages e175-e178 (June 2012) DOI: 10.1016/j.jccase.2012.03.001 Copyright © 2012 Japanese College of Cardiology Terms and Conditions

Figure 1 Management of pulmonary veno-occlusive disease (PVOD) at the French Referral Center for Pulmonary Hypertension. Reprinted, with permission, from Montani et al. [3]. PAH, pulmonary arterial hypertension; mPAP, mean pulmonary arterial pressure; PCWP, pulmonary capillary wedge pressure; PFT, pulmonary function test; PaO2, arterial oxygen tension; DLCO, diffusion capacity of the lung for carbon monoxide; SpO2, arterial oxygen saturation measured by pulse oxymetry; 6-MWT, 6min’ walk test; HRCT, high resolution computed tomography; BAL, bronchoalveolar lavage; NYHA, New York Heart Association; IPDE5, phosphodiesterase type-5 inhibitor; ERA, endothelin receptor antagonist. Journal of Cardiology Cases 2012 5, e175-e178DOI: (10.1016/j.jccase.2012.03.001) Copyright © 2012 Japanese College of Cardiology Terms and Conditions